|
Response according to HDFN risk, as established upon first trimester RBC antibody screening |
||
| Groups according to risk for HDFN |
Questionnaire 1 completed no |
Questionnaire 1 + 2 completed no (%) |
|
|
||
| A1. controls midwifery practice, screening negative |
61 |
58 (95) |
| A2. controls hospital practice, screening negative |
41 |
35 (85) |
| B. positive screening result, not confirmed |
24 |
21 (88) |
| C. clinically non-relevant antibodies |
48 |
44 (92) |
| D. clinically relevant non-RhD antibodies, not at risk HDFN (father antigen-negative) |
37 |
30 (81) |
| E. clinically relevant non-RhD antibodies, at risk HDFN (father antigen-positive) |
52 |
45 (87) |
| Total |
263 |
233 (89) |
|
No significant differences in response between the groups | ||
Koelewijn et al. BMC Pregnancy and Childbirth 2008 8:49 doi:10.1186/1471-2393-8-49 |
||